Insulet EBIT 2010-2024 | PODD
Insulet annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
- Insulet EBIT for the quarter ending December 31, 2024 was $0.109B, a 2.73% increase year-over-year.
- Insulet EBIT for the twelve months ending December 31, 2024 was $0.309B, a 40.41% increase year-over-year.
- Insulet 2024 annual EBIT was $0.309B, a 40.41% increase from 2023.
- Insulet 2023 annual EBIT was $0.22B, a 485.11% increase from 2022.
- Insulet 2022 annual EBIT was $0.038B, a 70.16% decline from 2021.
| Insulet Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $309 |
| 2023 | $220 |
| 2022 | $38 |
| 2021 | $126 |
| 2020 | $52 |
| 2019 | $50 |
| 2018 | $27 |
| 2017 | $-7 |
| 2016 | $-11 |
| 2015 | $-49 |
| 2014 | $-9 |
| 2013 | $-29 |
| 2012 | $-36 |
| 2011 | $-42 |
| 2010 | $-39 |
| 2009 | $-59 |
| Insulet Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2024-12-31 | $109 |
| 2024-09-30 | $88 |
| 2024-06-30 | $55 |
| 2024-03-31 | $57 |
| 2023-12-31 | $106 |
| 2023-09-30 | $55 |
| 2023-06-30 | $31 |
| 2023-03-31 | $28 |
| 2022-12-31 | $24 |
| 2022-09-30 | $3 |
| 2022-06-30 | $-27 |
| 2022-03-31 | $38 |
| 2021-12-31 | $50 |
| 2021-09-30 | $34 |
| 2021-06-30 | $26 |
| 2021-03-31 | $16 |
| 2020-12-31 | $-7 |
| 2020-09-30 | $24 |
| 2020-06-30 | $28 |
| 2020-03-31 | $8 |
| 2019-12-31 | $18 |
| 2019-09-30 | $17 |
| 2019-06-30 | $8 |
| 2019-03-31 | $7 |
| 2018-12-31 | $16 |
| 2018-09-30 | $7 |
| 2018-06-30 | $4 |
| 2018-03-31 | |
| 2017-12-31 | $-1 |
| 2017-09-30 | $2 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-5 |
| 2016-12-31 | $-4 |
| 2016-09-30 | $2 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $-8 |
| 2015-12-31 | $-13 |
| 2015-09-30 | $-15 |
| 2015-06-30 | $-14 |
| 2015-03-31 | $-7 |
| 2014-12-31 | $1 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-5 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $0 |
| 2013-09-30 | $-17 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-6 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-8 |
| 2012-06-30 | $-11 |
| 2012-03-31 | $-11 |
| 2011-12-31 | $-11 |
| 2011-09-30 | $-10 |
| 2011-06-30 | $-15 |
| 2011-03-31 | $-7 |
| 2010-12-31 | $-10 |
| 2010-09-30 | $-8 |
| 2010-06-30 | $-10 |
| 2010-03-31 | $-11 |
| 2009-12-31 | $-12 |
| 2009-09-30 | $-13 |
| 2009-06-30 | $-16 |
| 2009-03-31 | $-17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.646B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.329B | 27.30 |
| Boston Scientific (BSX) | United States | $151.960B | 38.05 |
| Stryker (SYK) | United States | $141.576B | 30.43 |
| EssilorLuxottica (ESLOY) | France | $131.433B | 0.00 |
| Medtronic (MDT) | Ireland | $108.503B | 15.84 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.360B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.382B | 26.36 |
| ResMed (RMD) | United States | $34.859B | 26.18 |
| GE HealthCare Technologies (GEHC) | United States | $31.175B | 15.16 |
| Agilent Technologies (A) | United States | $30.637B | 20.24 |
| Terumo (TRUMY) | Japan | $28.678B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.336B | 12.85 |
| Baxter (BAX) | United States | $15.890B | 11.43 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.790B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.119B | 17.50 |
| Bio-Rad Laboratories (BIO) | United States | $6.788B | 23.50 |
| Prestige Consumer Healthcare (PBH) | United States | $4.059B | 19.37 |
| Perrigo (PRGO) | Ireland | $3.496B | 10.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 28.78 |
| Haemonetics (HAE) | United States | $3.214B | 15.12 |
| Envista Holdings (NVST) | United States | $2.745B | 22.19 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 15.23 |
| LeMaitre Vascular (LMAT) | United States | $2.092B | 47.73 |
| QuidelOrtho (QDEL) | United States | $1.928B | 16.15 |
| AtriCure (ATRC) | United States | $1.715B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.258B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.250B | 19.63 |
| BioLife Solutions (BLFS) | United States | $1.174B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.129B | 10.87 |
| Neogen (NEOG) | United States | $1.092B | 13.97 |
| InMode (INMD) | Israel | $1.003B | 9.18 |
| Phibro Animal Health (PAHC) | United States | $0.765B | 11.73 |
| Evolus (EOLS) | United States | $0.746B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.596B | 0.00 |
| CeriBell (CBLL) | United States | $0.587B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.574B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.61 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.493B | 0.00 |
| Surmodics (SRDX) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.419B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.346B | 15.02 |
| Verano Holdings (VRNOF) | United States | $0.307B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 24.82 |
| ZimVie (ZIMV) | United States | $0.264B | 15.78 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.237B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 4.43 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.89 |
| Brainsway (BWAY) | Israel | $0.168B | 52.29 |
| Organigram Global (OGI) | Canada | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.99 |
| Jin Medical (ZJYL) | China | $0.140B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.121B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.86 |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 0.00 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.11 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |